For the integumentary system, the terms used included “GLP-1 receptor agonists” AND “skin” as well as “GLP-1 receptor agonists” AND “dermatology.” For endocrinological aspects, the terms “GLP 1 receptor agonists” AND “thyroid cancer”, “GLP-1 receptor” AND “Endocrine pancreas”, “GLP-1” AND “adrenal glands”, and “GLP-1” AND “medullary thyroid cancer” were employed. The gene discussed is GCG; the disease is medullary thyroid gland carcinoma.